Hugh Gallagher, MD

Hugh Gallagher, MD, is a Consultant Nephrologist at Epsom and St Helier NHS Trust and a Visiting Professor in the Academic Unit of Primary Care and Population Sciences at the University of Southampton.

Articles by Hugh Gallagher, MD

ATTACK: Should Patients With CKD Start Aspirin for Primary Prevention?

ByHugh Gallagher, MD

October 23rd 2026

Hugh Gallagher, MBBS, PhD, discusses a 27% lower point estimate for cardiovascular events with aspirin that was not significant.

Hugh Gallagher, MD

Articles by Hugh Gallagher, MD

ATTACK: Should Patients With CKD Start Aspirin for Primary Prevention?

Latest Updated Articles

Trending on HCPLive

Retatrutide Lowers Albuminuria, Glomerular Pressure in Obesity and CKD

Sleeve Gastrectomy Improves Heart, Kidney MRI Markers in Youth-Onset T2D

TELIGAN: Telitacicept Preserves eGFR Through 2 Years in IgA Nephropathy

Ravulizumab Receives FDA Accelerated Approval for IgA Nephropathy

RAINIER: Povetacicept Cuts Proteinuria, Gd-IgA1 in IgA Nephropathy